Yoav Messinger, MD is the Medical Director of the Cancer and Blood Disorders (Pediatric Hematology/Oncology) at Children’s Hospitals of Minnesota, Minneapolis, Minnesota. He has collaborated with the first successful strategy of tolerance induction in Infantile Pompe disease. He has many years of experience with the use of B-cell directed agents such as rituximab and bortezomib.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)